NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.905
-0.015 (-0.78%)
At close: Sep 30, 2026, 4:00 PM EDT
1.910
+0.005 (0.26%)
After-hours: Sep 30, 2026, 4:10 PM EDT
NervGen Pharma Employees
NervGen Pharma had 10 employees as of December 31, 2025. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
n/a
Profits / Employee
-$4,362,912
Market Cap
204.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | 3 | 42.86% | 9 | 1 |
| Dec 31, 2019 | 7 | - | - | 7 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Entrada Therapeutics | 152 |
| Adagene | 128 |
| Foghorn Therapeutics | 106 |
| Alector | 103 |
| Keros Therapeutics | 92 |
| Cartesian Therapeutics | 75 |
| Anavex Life Sciences | 34 |
NGEN News
- 7 hours ago - NervGen Pharma Transcript: R&D Day 2026 - Transcripts
- 5 days ago - NervGen Pharma to restate previously filed financial statements - TheFly
- 5 days ago - NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments - GlobeNewsWire
- 21 days ago - NervGen to Host Inaugural R&D Day on September 30, 2026 - GlobeNewsWire
- 6 weeks ago - NervGen Pharma reports Q2 EPS (C$0.37) vs. (C$0.13) last year - TheFly
- 6 weeks ago - NervGen Pharma Earnings release: Q2 2026 - Filings
- 6 weeks ago - NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - NervGen Pharma price target lowered to $15 from $18 at H.C. Wainwright - TheFly